Clinical trial

Vascular Impact of Omega-3 in Metabolic Syndrome

NCT01566188

Study summary

ClinicalTrials.gov

Vascular Impact of Omega-3 in Metabolic Syndrome

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIETARY_SUPPLEMENT · Unmapped registry intervention omega-3 from vegetal origin Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-01-01

PhaseNA

Conditions

Essential Hypertensionverified · MONDO: essential hypertension

Metabolic Syndromeverified · MONDO: abdominal obesity-metabolic syndrome

Interventions

omega-3 from vegetal originDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

University Hospital, Rouenlead sponsor

Mapped research locations

ParisFrance1 ToulouseFrance1 RouenFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01566188 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.